Hologic (NASDAQ 🙂 announced Wednesday its second quarter results. They beat forecasts by analysts and generated more revenue than expected.

Hologic reported earnings per share at $2.07 for revenue $1.44B. Investing.com polled analyst to predict EPS at $1.6 on $1.29B revenue.

The Hologic shares have increased 10% since the start of the year but are still 12.59% below the $81.04 52-week high set on September 10, 2021. The Hologic shares are outperforming their peers, which has fallen 20.32% since the beginning of the year.

After-hours trading on Hologic shares fell 1.54% following the release.

The Hologic earnings are in line with other healthcare sector leaders this month

Hologic’s April report is following an earnings beat by UnitedHealth, who reported EPS $5.49 on revenue revenue of $80.15B. Forecasts for EPS $5.36 on revenue revenue of $78.73B.

J&J had beat expectations on April 19 with first quarter EPS of $2.67 on revenue of $23.43B, compared to forecast for EPS of $2.59 on revenue of $23.62B.

Keep up to date with all the earnings reports coming soon by visiting Investing.com’s earnings calendar